S 
64.89
+2.16%
Close of 9 Nov 2026, in USD
Search any instrument
Reference data, closing prices and charts across 45,000 companies, plus crypto, commodities and currencies.
At a glance
Figures in USD, from our data supplier.
Revenue, before interest expense
$24.53bn
FY2016FY2025
Net income
$3.52bn
FY2016FY2025
Total assets
$555.86bn
FY2016FY2025
Shareholders' equity
$37.63bn
FY2016FY2025
Income statement
Fiscal years
| FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue, before interest expense | $24.53bn | $25.02bn | $23.91bn | $17.37bn | $18.21bn | $18.19bn | $18.74bn | $11.24bn | $10.32bn | $9.54bn |
| Research and development | — | — | — | — | — | — | — | — | $10.0m | $10.0m |
| Operating income | $4.90bn | $4.26bn | $4.22bn | $4.50bn | $3.95bn | $3.36bn | $3.47bn | $6.66bn | $3.18bn | $5.06bn |
| Net income | $3.52bn | $3.15bn | $3.09bn | $3.30bn | $2.84bn | $2.41bn | $2.41bn | $2.23bn | $2.06bn | $1.96bn |
| Diluted earnings per share | 6.87 | 6.28 | 6.04 | 6.49 | 5.32 | 4.93 | 5.01 | 4.71 | 4.35 | 4.14 |
Balance sheet
At each fiscal year end
| FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Total assets | $555.86bn | $523.18bn | $489.25bn | $469.90bn | $453.94bn | $428.04bn | $390.68bn | $325.04bn | $301.49bn | $279.83bn |
| Cash and short-term investments | $19.57bn | $95.81bn | $89.17bn | $82.42bn | $84.83bn | $65.68bn | $62.94bn | $40.18bn | $46.64bn | $41.03bn |
| Total liabilities | $516.53bn | $481.58bn | $449.42bn | $432.12bn | $418.43bn | $395.25bn | $361.03bn | $299.12bn | $277.66bn | $257.38bn |
| Debt | $148.83bn | $101.42bn | $96.82bn | $89.07bn | $86.58bn | $81.77bn | $78.28bn | $64.84bn | $68.31bn | $42.71bn |
| Shareholders' equity | $37.63bn | $39.64bn | $37.99bn | $35.88bn | $33.92bn | $31.17bn | $27.71bn | $25.27bn | $23.84bn | $22.00bn |
| Shares outstanding | 512m | 501m | 512m | 509m | 534m | 490m | 481m | 474m | 474m | 474m |
Latest quarters
By quarter end
| Jun 2026 | Mar 2026 | Dec 2025 | Sept 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sept 2024 | |
|---|---|---|---|---|---|---|---|---|
| Revenue, before interest expense | $1.82bn | $6.17bn | $6.76bn | $5.95bn | $6.24bn | $6.05bn | $2.15bn | $6.24bn |
| Operating income | $1.82bn | $1.57bn | $606.8m | $1.38bn | $1.47bn | $1.42bn | $1.06bn | $1.25bn |
| Net income | $1.33bn | $1.15bn | $378.6m | $1.01bn | $1.10bn | $1.05bn | $287.2m | $917.3m |
| Diluted earnings per share | 2.77 | 2.38 | 0.74 | 1.97 | 2.14 | 2.06 | 0.57 | 1.83 |
| Total assets | — | $577.60bn | $555.89bn | $553.71bn | $532.32bn | $527.75bn | $523.18bn | $527.16bn |
| Cash and short-term investments | — | $102.54bn | $102.27bn | $103.99bn | $97.00bn | $97.50bn | $24.91bn | $96.07bn |
| Debt | — | $102.76bn | $104.51bn | $100.60bn | $100.54bn | $98.40bn | $93.23bn | $99.66bn |
| Shareholders' equity | — | $41.77bn | $40.99bn | $40.93bn | $40.45bn | $40.18bn | $39.64bn | $39.61bn |
Financial ratios
Data as of 21 Sept 2026
| FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2017 | FY2016 | FY2015 | FY2014 | FY2013 | FY2012 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating margin | 20.0% | 17.0% | 17.6% | 25.9% | 21.7% | 18.5% | — | — | — | — | — | — |
| Net margin | 14.3% | 12.6% | 12.9% | 19.0% | 15.6% | 13.3% | — | — | — | — | — | — |
| Return on equity | 9.3% | 7.9% | 8.1% | 9.2% | 8.4% | 7.7% | — | — | — | — | — | — |
| Return on assets | 0.6% | 0.6% | 0.6% | 0.7% | 0.6% | 0.6% | — | — | — | — | — | — |
| Revenue growth | -2.0% | 4.7% | 37.6% | -4.6% | 0.1% | -2.9% | — | — | — | — | — | — |
| Earnings growth | 11.7% | 1.9% | -6.4% | 16.1% | 17.7% | 0.3% | — | — | — | — | — | — |
| Current ratio | 0.36x | 0.33x | 0.34x | 0.31x | 0.30x | 0.29x | — | — | — | — | — | — |
| Debt to equity | 3.94x | 2.66x | 2.66x | 2.47x | 2.54x | 2.61x | — | — | — | — | — | — |
| Equity ratio | 6.8% | 7.6% | 7.8% | 7.6% | 7.5% | 7.3% | — | — | — | — | — | — |
| Interest coverage | 0.42x | 0.34x | 0.36x | 0.67x | 1.41x | 0.97x | — | — | — | — | — | — |
| R&D as a share of sales | — | — | — | — | — | — | 0.1% | 0.1% | 0.1% | 0.1% | 0.1% | 0.1% |
| Buybacks as a share of market value | -2.1% | 2.0% | -0.6% | 4.7% | -9.0% | -1.9% | — | — | — | — | — | — |
Growth per year
Compound annual rate
| 3 years | 5 years | 10 years | |
|---|---|---|---|
| Revenue | 12.2% | 6.2% | 10.0% |
| Operating income | 2.9% | 7.8% | -0.8% |
| Net income | 2.1% | 7.8% | 7.7% |
Average margins
Over each period
| 1 year | 3 years | 5 years | 10 years | |
|---|---|---|---|---|
| Operating margin | 18.5% | 19.7% | 19.8% | 26.2% |
| Net margin | 13.4% | 14.4% | 14.4% | 15.4% |
Valuation history
At each fiscal year end
| FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Price to earnings | 7.8 | 5.2 | 5.1 | 4.3 | 5.8 | 6.0 | 7.6 | 7.5 | 10.7 | 9.1 |
| Price to sales | 1.1 | 0.7 | 0.7 | 0.8 | 0.9 | 0.8 | 1.0 | 1.5 | 2.1 | 1.9 |
Market value over time
31 Oct 2016 to 18 Sept 2026, in USD
$18.32bn$38.59bn
Share price return
Finished calendar years
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Return | 55% | 14% | 4% | -9% | 4% | -22% | 7% | -22% | 18% | 21% |
Dividends and splits
Per share, in the currency the company pays
Paid for 0 years.
- 2-for-1 split · 15 Oct 2012
Sources and methodology
- Data on this tab
- Our data supplier
- Chart on the Overview
- TradingView
Nothing here is investment advice. Prices can be delayed or wrong, so check with the exchange before relying on them. Data for this page. How we cover markets.